Abstract
Introduction
Primary breast sarcomas (PBA) are rare and aggressive malignant tumours 1, 2 . Barring phyllodes tumours, they account for less than 0.1% of all malignant tumours of the breast 3 . Among these, angiosarcoma accounts for less than 0.05% of all malignant neoplasms of the breast 3 . These neoplasms arise from vascular endothelial cells 4, 5 . They can occur de novo (primary) or, more commonly, as a consequence of breast carcinoma treatment (secondary) 1 . In this article, we will discuss only primary angiosarcomas.
Case report
A 24-year-old woman with no significant past medical history presented with a mass located below her right breast for the past 2 months. There was no reported history of family breast cancer. Physical examination revealed a painless mass in her right breast, measuring 10 × 5 cm in diameter. There was no evidence of clinical right axillary lymphadenopathy. The rest of the physical examination was normal; particularly, there were no abnormal findings in the left breast. Ultrasonography of the breast showed a hyperechoic and hypervascular mass. The diagnostic of phyllode tumour was suggested. A core needle biopsy identified the malignant nature of the mass. Angiosarcoma was suspected, and the diagnosis was confirmed by positive results for CD31 and CD34. A right radical mastectomy, including right axillary lymph node dissection, was performed. Macroscopic examination showed a white and well-circumscribed mass with friable consistency, covering an area measuring 16 × 11 × 6 cm. At the centre of this mass, necrosis and blood lakes were found.
Histopathological examination showed that the mass was composed of vascular channels. The cells had high nuclear grade and were arranged in sheets (Figure 1 ). The tumour showed high mitotic count (24/10 HPF), high nuclear grade and necrosis ( Figure 2 ). There was dermal invasion, but epidermis was intact. There is no lymph node metastasis. The neoplastic cells expressed CD31 and CD34 antigen (Figure 3 ), but they did not express cytokeratin, epithelial membrane antigen, desmin and smoothmuscle actin. Therefore, the diagnosis of angiosarcoma, of World Health Organization classification was performed.
After surgery, the patient was irradiated with a total dose of 70.2 Gy (1.8 Gy/day, 5 days a week). Afterwards, systemic chemotherapy was started, which consisted of intravenously administering adriamycin at 60 mg (Day 1) and ifosfamide at 1.5 g (Day 1-3). Twelve months after tumour resection, the patient was free of disease.
Discussion
Most angiosarcomas are secondary to radiotherapy treatments or to arm lymphoedema. Primary angiosarcomas represent only 20% of all breast angiosarcomas 1 . However, angiosarcoma arises in the breast more often than in any other organ 4, 5 . Because of the rarity of PBA, most literature about these cases was in the form of case reports and dealt with only a few patients. It arises in young women, usually during the third and fourth decades of life 4 . Some authors suggest that these tumours are hormone dependent because many cases of angiosarcoma have been reported through pregnancy 6 . However, no evidence supports this hypothesis because oestrogen receptors are rarely positive. In our case, both oestrogen and progesterone receptors were negative.
Patients with PBA present with a painless palpable mass that may be growing rapidly, and as seen in our case. Often, this tumour covers an area of more than 4 cm 1, 4, 7 . For this reason, distant metastases are frequent 1, 8 . This tumour may present with blue or purple discoloration of the skin 4 . Mammographic characteristics can establish the diagnosis, but, frequently, as in our case, it is nonspecific 5, 7 . Sonography and Doppler sonography are more specific and show angiosarcoma as a heterogeneous, hyperechoic and hypervascular mass that is associated with the disruption of normal breast architecture 4, 5 . Magnetic resonance imaging is helpful in identifying lobular masses that appear hypointense on T1-weighted and hyperintense on T2-weighted images 7 and is useful in determining extent of tumour.
Microscopically, it can be seen that angiosarcoma consists of a heterogeneous group of lesions. Three grades of angiosarcoma are described, depending on the tumour differentiation. Low-grade or Type I tumours consist of anastomosing vascular channels that proliferate diffusely in Grade I must be distinguished from benign lesions such as haemangioma, especially on biopsy, and Grade III from metaplastic carcinoma, fibrosarcoma and reactive spindle cell proliferative lesion 1, 9 . Complete excision and sufficient sampling of the tumour are often necessary to perform diagnosis accurately. In some cases, immunohistochemical examination can be helpful, especially on core needle biopsy. Tumour cells in angiosarcoma are positive for Factor VIII, CD31 and CD34 5 . In our case, on initial core needle biopsy, the positivity of tumour cells to CD34 and CD31 antigen confirmed the diagnosis of angiosarcoma.
PBA have a poor prognosis. In an analysis of 69 patients with non-metastatic angiosarcoma of the breast, Sher et al. found that the estimated median overall and recurrencefree survival times were 100 and 37 months, respectively, suggesting that the disease is aggressive 2 . The 5-year disease-free survival rate is 76% for low-grade tumours (Grade 1) and 15% for high-grade tumours (Grade 3) 5 . In this case, the patient had a Grade 3 tumour with no metastases and was free of recurrence even after 10 months post-surgery.
Prognosis depends on tumour grade, tumour size at diagnosis and margin status at the time of surgery. The most important factor was tumour grade 4, 5, 7 . However, some authors suggest that tumour size is the most important prognostic factor 2, 3 . Furthermore, in their study involving 49 patients with PBA, Nascimento et al. showed that there was no correlation between tumour grade and disease-free survival and overall survival 3 . Visceral metastases are common. The most frequent metastatic site is the liver, followed by lung, lymph nodes, bones and bone marrow 1, 5 . Metastases to the contralateral breast have also been reported 4 . Because of the rarity of PBA, the treatment lacks uniformity. Mastectomy without axillary node dissection is the best choice of treatment, for metastasis of the regional lymph nodes at diagnosis in uncommon 1, 7 . In such cases, biopsy plays a major role in the diagnosis and helps to avoid axillary node dissection. Conserving treatment is recommended for patients with smaller tumours 6 . Chemotherapy and radiation therapy can be used as adjuvant treatments because PBA have a tendency to reoccur 2 . Some authors suggest adjuvant radiation therapy when surgical margins are positive, when surgical margins are less than 2 cm 1 and when palliative treatment of pain secondary to bone metastasis is required 5, 7 .
Conclusion
Therapeutic recommendations are difficult to establish due to the rarity of these tumours. Therefore, prospective studies are needed to fully codify the role of adjuvant treatment for PBA. It is important to report these cases and to present, primarily, treatments and the patient's evolution.
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